Clinical trials in small populations - Scientific guideline
HumanClinical trialsScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document addresses problems associated with clinical trials when there are limited numbers of patients available to study.
Keywords: Small population, sample size, surrogate endpoint, patient registry, external control, noise-to-effect ratio, randomisation, control group, matching, stratification, case series, case reports
Current effective version
Related content
- Biostatistics
- Scientific guidelines: paediatrics
- Directive 2001/83/EC
Points to consider on the estimation and reporting of the prevalence of a condition for orphan designation- Application with 1. Meta-analyses; 2. One pivotal study
- Clinical evaluation of diagnostic agents
- ICH E1 Population exposure: the extent of population exposure to assess clinical safety
- ICH E4 Dose response information to support drug registration
- ICH E8 General considerations for clinical trials
- ICH E9 Statistical principles for clinical trials
- ICH E10 Choice of control group in clinical trials
- ICH E11 Clinical investigation of medicinal products in the paediatric population
- Methodological issues in confirmatory clinical trials planned with an adaptive design